| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/01/2009 | EP2075249A2 Indolylmaleimide derivatives |
| 07/01/2009 | EP2074115A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/01/2009 | EP2074113A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 07/01/2009 | EP2074112A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 07/01/2009 | EP2074111A2 Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| 07/01/2009 | EP2074110A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor |
| 07/01/2009 | EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 07/01/2009 | EP2074099A1 Quinolinone derivatives |
| 07/01/2009 | EP2074098A2 Quinoline compounds |
| 07/01/2009 | EP2074095A2 Process for the preparation of imatinib and intermediates thereof |
| 07/01/2009 | EP2074093A2 Matrix metalloproteinase inhibitors |
| 07/01/2009 | EP2074089A2 Organic compounds |
| 07/01/2009 | EP2074086A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 07/01/2009 | EP2074083A1 New sulfonamide derivatives as bradykinin antagonists |
| 07/01/2009 | EP2073807A1 Pharmaceutical combinations |
| 07/01/2009 | EP2073799A2 Novel agents of calcium ion channel modulators |
| 07/01/2009 | EP2001867B1 Pyrimidine, quinazoline, pteridine and triazine derivatives |
| 07/01/2009 | EP1861365B1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 07/01/2009 | EP1784393B1 Quinazolines useful as modulators of ion channels |
| 07/01/2009 | EP1776339B1 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 07/01/2009 | EP1740576B1 Novel piperidine substituted diaminothiazoles |
| 07/01/2009 | EP1697343B1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 07/01/2009 | EP1691810A4 Substituted piperazines |
| 07/01/2009 | EP1686999B1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 07/01/2009 | EP1682126B1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 07/01/2009 | EP1576159B1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor |
| 07/01/2009 | CN101472914A Inhibitors of C-FMS kinase |
| 07/01/2009 | CN101472913A Prodrug of cinnamide compound |
| 07/01/2009 | CN101472912A Pyridine and pyrazine derivatives as MNK kinase inhibitors |
| 07/01/2009 | CN101472911A Trisubstituted 1,2,4-triazoles |
| 07/01/2009 | CN101472910A 1- [(4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 07/01/2009 | CN101468984A N-oxyde of n-phenyl-2-pyrimidine-amine derivatives |
| 07/01/2009 | CN101468965A Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 07/01/2009 | CN100506817C Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 07/01/2009 | CN100506816C Yellow dye compound and its ink composition |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553968 Synthesis of nicotine derivatives from nicotine |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553857 S-omeprazole magnesium |
| 06/30/2009 | US7553856 Crystalline form of omeprazole |
| 06/30/2009 | US7553841 Amino cyclobutylamide modulators of chemokine receptor activity |
| 06/30/2009 | US7553798 Heterocyclic carboxamides with microbiocidal activity |
| 06/30/2009 | US7553336 Brightening direct dyes for keratin fibers and colorants containing these compounds |
| 06/30/2009 | CA2307111C Novel pyridazine derivatives and drugs containing the same as the active ingredient |
| 06/28/2009 | CA2636535A1 3'-fluoro-5'-hydroxythalidomide and derivatives thereof |
| 06/25/2009 | WO2009079624A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | WO2009079225A1 Cyclopropyl amine derivatives |
| 06/25/2009 | WO2009078992A1 Linear tricyclic compounds as p38 kinase inhibitors |
| 06/25/2009 | WO2009078481A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | WO2009078432A1 1-alkyl-4-amino-1h-pyrazole-3-carboxamide compound |
| 06/25/2009 | WO2009077990A1 Aminotriazole derivatives as alx agonists |
| 06/25/2009 | WO2009077728A1 Indoles and their therapeutic use |
| 06/25/2009 | WO2009077533A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists |
| 06/25/2009 | WO2009077392A1 Azomethine direct dyes or reduced precursors of these dyes obtained from 2-amino-3-hydroxypyridine, and hair dyeing process using these dyes and precursors |
| 06/25/2009 | WO2009077390A2 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 4,5 diaminopyrazole, and hair dyeing process using these dyes or precursors |
| 06/25/2009 | WO2009077367A1 Novel pyrazole-substituted arylamides |
| 06/25/2009 | WO2009077365A1 Novel imidazole-substituted arylamides |
| 06/25/2009 | WO2009077059A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
| 06/25/2009 | WO2009077052A2 Process for preparing tetrahydroquinoline derivatives |
| 06/25/2009 | WO2009076747A1 Viral polymerase inhibitors |
| 06/25/2009 | WO2009061761A3 Fungicidal heterocyclic amines |
| 06/25/2009 | WO2009052200A3 Human adam-10 inhibitors |
| 06/25/2009 | WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors |
| 06/25/2009 | WO2009019469A9 Pyrrolidines as catalyst compounds |
| 06/25/2009 | WO2009017951A3 Pesticides and uses thereof |
| 06/25/2009 | US20090163721 Crystalline solids of carvedilol and processes for their preparation |
| 06/25/2009 | US20090163718 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES |
| 06/25/2009 | US20090163555 Isolated optically active stereoisomers are useful for enhancing an immuneresponse, for treating autoimmune diseases and asantitumor agents, bacteriacides, fungicides or viricides; one pot synthesis of1-(3-a3S,5R-1-(3-amino-5-carboxy-2-oxopyrrolidin-3-ylmethyl)pyridinium bromide hydrobromide |
| 06/25/2009 | US20090163553 Benzimidazole compound crystal |
| 06/25/2009 | US20090163552 Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
| 06/25/2009 | US20090163546 Diacylglycerol acyltransferase inhibitors |
| 06/25/2009 | US20090163542 5-ht7 receptor antagonists |
| 06/25/2009 | US20090163540 Quinine Sulfate Polymorphs, Processes of Preparing, Compositions and Uses Thereof |
| 06/25/2009 | US20090163518 Novel Compounds |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163511 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
| 06/25/2009 | US20090163508 Amide compound |
| 06/25/2009 | US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/25/2009 | US20090163502 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 06/25/2009 | US20090163498 Aryl Sulfonamides |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090163477 Phthalazinone derivatives |
| 06/25/2009 | US20090163470 Thiazolylidine urea and amide derivatives and methods of use thereof |
| 06/25/2009 | US20090163467 New compounds |
| 06/25/2009 | US20090163462 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 06/25/2009 | US20090162694 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 06/25/2009 | US20090160326 Organic electroluminescence material and element using the same |
| 06/25/2009 | US20090160315 Organic electroluminescence material and element using the same |
| 06/25/2009 | DE102007061963A1 Pyridazinonderivate Pyridazinone derivatives |
| 06/25/2009 | DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
| 06/25/2009 | CA2709571A1 Process for preparing tetrahydroquinoline derivatives |
| 06/25/2009 | CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | CA2709081A1 Cyclopropyl amine derivatives |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | CA2708791A1 Novel imidazole-substituted arylamides |